Nicholas Bingham, MBBS, FRACP, FRCPA, Alfred Health & Monash University, Melbourne, Australia, briefly discusses the sensitivity and application of liquid biopsy to detect cell-free DNA in patients with extramedullary multiple myeloma, and further highlights the value of using this approach in clinical practice. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.